Selective decontamination of the digestive tract for the prevention of infection in acute leukemia.
Dekker
A
A
Gaus
W
W
Kurrle
E
E
de Vries-Hospers
H
H
van der Waaij
D
D
Wendt
F
F
D000208:Acute Disease; D000666:Amphotericin B / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000517:prevention & control*; D004064:Digestive System / Q000382:microbiology*; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D009355:Neomycin / Q000627:therapeutic use*; D011112:Polymyxin B / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D011113:Polymyxins; D000666:Amphotericin B; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D009355:Neomycin; D011112:Polymyxin B; D013420:Sulfamethoxazole